CLINICAL_TRIALS
trial_result
· 2014-07-04
Clinical Trial Update: Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection [Phase 2]
Summary
Phase 2 trial update for intravaginal LACTIN-V aimed at preventing recurrent urinary tract infections has completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Urinary Tract Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-07-04